This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Drug Therapy, Other  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Drug Therapy  • Alert me on articles by topic

Steven J. Wang, MD; Karine Peyrollier, PhD; Lilly Y. Bourguignon, PhD

Arch Otolaryngol Head Neck Surg. 2007;133(3):281-288.

Objective  To investigate the downstream molecular targets of hyaluronan (HA)-CD44 and phospholipase C (PLC)-mediated calcium ion (Ca²⁺) signaling in head and neck squamous cell carcinoma (HNSCC). Hyaluronan is a ligand for the CD44 receptor, which interacts with multiple signaling pathways to influence cellular behavior. We recently determined that HA-CD44 interaction promotes PLC-mediated Ca²⁺ signaling and cisplatin resistance in HNSCC.

Design  Proliferation of HNSCC tumor cells and topoisomerase (Topo) II enzymatic activity, including DNA-cleavable complex formation and DNA decatenation, were analyzed in the presence or absence of HA, the Topo II poison etoposide (VP-16), and various inhibitors of PLC and Ca²⁺-calmodulin kinase II (CaMKII) signaling.

Results  Treatment with HA promoted Topo II phosphorylation, suggesting that HA can modulate Topo II activity. Topoisomerase II–mediated DNA cleavable complex formation was increased by VP-16, and this increase was significantly enhanced by noncytotoxic doses of the PLC inhibitor U73122 and the CaMKII inhibitor KN-62, implicating PLC and CaMKII in Topo II regulation. However, the drug- and inhibitor-mediated increase in DNA cleavable complex formation was reduced with HA pretreatment. Inhibitors of PLC and CaMKII also enhanced VP-16 inhibition of Topo II–mediated DNA decatenation. Treatment with HA reduced VP-16 cytotoxic activity. On the other hand, U73122 and KN-62 enhanced VP-16 cytotoxic activity and reduced the ability of HA to promote VP-16 resistance.

Conclusion  Our results suggest that HA, PLC, and CaMKII are upstream regulators of Topo II–mediated DNA metabolism in HNSCC and that this signaling pathway could be a promising target for the development of novel therapies against HNSCC.

Author Affiliations: Department of Otolaryngology–Head and Neck Surgery (Dr Wang) and Endocrine Unit, Department of Medicine (Drs Peyrollier and Bourguignon), Veterans Affairs Medical Center, University of California, San Francisco.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
Bourguignon et al.
J. Biol. Chem. 2008;283:17635-17651.
ABSTRACT | FULL TEXT